Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort - Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, Lauren Véronèse, Bruno Pereira, Sandy Amorim, Florence Cymbalista, Charles Herbaux, Sophie de Guibert, Damien Roos-Weil, Bénédicte Hivert, Thérèse Aurran, Jehan Dupuis, Anaise Blouet, Emmanuelle Tchernonog - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Springer, Annals of Hematology, 4(100), p. 987-993, 2021

DOI: 10.1007/s00277-021-04419-w

Links

ORCID
Springer | PDF

Tools

Export citation

Search in Google Scholar

Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort

Journal article published in 2021 by Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, Lauren Véronèse, Bruno Pereira, Sandy Amorim, Florence Cymbalista, Charles Herbaux, Sophie de Guibert, Damien Roos-Weil, Bénédicte Hivert, Thérèse Aurran, Jehan Dupuis, Anaise Blouet, Emmanuelle Tchernonog and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO